Assessment of Carrier-Free Metallacarboranes for Targeted Radiation Therapies PBFT and BNCT: Comparative Cellular Effects and Dosimetry Studies with [<i>o</i>-FESAN]⁻ in Breast Cancer Cells

<b>Background:</b> Ferrabis(dicarbollide) ([<i>o</i>-FESAN]⁻) in combination with proton–boron fusion therapy (PBFT) or boron neutron capture therapy (BNCT) are promising alternative radiation modalities for the treatment of breast cancer. The aim of th...

Full description

Bibliographic Details

Published in:	Pharmaceuticals
Main Authors:	Salvatore Di Maria, Teresa Pinheiro, Luís Cerqueira Alves, Valeria Bitonto, Nicoletta Protti, Simonetta Geninatti Crich, Kai Nishimura, Hiroyuki Nakamura, António P. Matos, Catarina I. G. Pinto, Filipa Mendes, Francesc Teixidor, Clara Viñas, Fernanda Marques
Format:	Article
Language:	English
Published:	MDPI AG 2025-10-01
Subjects:	Ferrabis(dicarbollide) cancer treatment particle radiation therapies proton boron fusion therapy (PBFT) boron neutron capture therapy (BNCT) breast cancer
Online Access:	https://www.mdpi.com/1424-8247/18/10/1491